The Protective Effect of Acylation on the Stability of Anisoylated Plasminogen Streptokinase Activator Complex in Human Plasma
- 1 January 1987
- journal article
- Published by Springer Nature in Drugs
- Vol. 33 (3) , 57-63
- https://doi.org/10.2165/00003495-198700333-00007
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- High-dose, brief-duration intravenous infusion of streptokinase in acute myocardial infarction: Description of effects in the circulationThe American Journal of Cardiology, 1986
- Thrombolytic therapy in the eighties.1986
- Clinical effects and kinetic properties of intravenous APSAC — anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarctionInternational Journal of Cardiology, 1986
- Induction of a sustained fibrinolytic response by BRL 26921 in vitroThrombosis Research, 1985
- Isolation of a human tissue-type plasminogen-activator genomic DNA clone and its expression in mouse L cellsGene, 1985
- Assessment of Anti-Streptokinase Antibody Levels in Human Sera Using a Microradioimmunoassay ProcedureThrombosis and Haemostasis, 1984
- Catabolic Pathways for Streptokinase, Plasmin, and Streptokinase Activator Complex in MiceJournal of Clinical Investigation, 1982
- The fibrin plate method for estimating fibrinolytic activityArchives of Biochemistry and Biophysics, 1952